LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH ... [Antimicrob Agents Chemother (Bethesda). 1963]

CLINICAL AND LABORATORY STUDIES OF OXACILLIN IN STAPHYLOCOCCAL INFECTIONS OF INFANTS AND CHILDREN. [Antimicrob Agents Chemother (Bethesda). 196...]
CLINICAL AND LABORATORY STUDIES OF OXACILLIN IN STAPHYLOCOCCAL INFECTIONS OF INFANTS AND CHILDREN.
ROSENTHAL IM, ADAMS BW, METZGER WI. Antimicrob Agents Chemother (Bethesda). 1963; 161:227-30.
COLISTIN THERAPY IN INFANTS AND CHILDREN. [Am J Dis Child. 1965]
COLISTIN THERAPY IN INFANTS AND CHILDREN.
WALKER SH, PATRON LR. Am J Dis Child. 1965 Mar; 109:204-11.
CLINICAL ASSESSMENT OF 5-METHYL-3-PHENYL-4-ISOAZOXLYL PENICILLIN IN STAPHYLOCOCCAL INFECTIONS. [Acta Chir Scand. 1964]
CLINICAL ASSESSMENT OF 5-METHYL-3-PHENYL-4-ISOAZOXLYL PENICILLIN IN STAPHYLOCOCCAL INFECTIONS.
MALMSTROEM-GROWTH A, OBERG G. Acta Chir Scand. 1964 Jun; 127:584-7.
Review Prophylactic antibiotics in cystic fibrosis: a conviction without evidence? [Pediatr Pulmonol. 2005]
Review Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?
Smyth A. Pediatr Pulmonol. 2005 Dec; 40(6):471-6.
Review Inhaled bronchodilators for cystic fibrosis. [Cochrane Database Syst Rev. 2005]
Review Inhaled bronchodilators for cystic fibrosis.
Halfhide C, Evans HJ, Couriel J. Cochrane Database Syst Rev. 2005 Oct 19; (4):CD003428. Epub 2005 Oct 19.

Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs. [Br Med J. 1980]
Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.
Enat R, Pollack S, Ben-Arieh Y, Livni E, Barzilai D. Br Med J. 1980 Apr 5; 280(6219):982-3.
Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections. [Yale J Biol Med. 1966]
Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections.
Thornton GF, Andriole VT. Yale J Biol Med. 1966 Aug; 39(1):9-20.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH CYSTIC FIBROSIS.
LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH CYSTIC FIBROSIS.
Antimicrob Agents Chemother (Bethesda). 1963 ;161:237-42.

PubMed
Identification and quantitation of precipitins against Pseudomonas aeruginosa in...
Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel.
Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Jun ;81(3):298-308.

PubMed
Prolonged neonatal jaundice in cystic fibrosis.
Prolonged neonatal jaundice in cystic fibrosis.
Arch Dis Child. 1971 Dec ;46(250):805-9.

PubMed
Ocular findings in cystic fibrosis of the pancreas: a preliminary report.
Ocular findings in cystic fibrosis of the pancreas: a preliminary report.
Arch Ophthalmol. 1960 Mar ;63:391-401.

PubMed
The rheology of human lung mucus.
The rheology of human lung mucus.
Ann N Y Acad Sci. 1963 Mar 30 ;106:746-54.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed